Tenet Healthcare (NYSE:THC – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported $3.44 EPS for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49, Zacks reports. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. Tenet Healthcare updated its FY 2025 guidance to 11.740-12.840 EPS.
Tenet Healthcare Trading Up 0.6 %
THC traded up $0.75 during trading on Thursday, hitting $126.94. 231,518 shares of the stock were exchanged, compared to its average volume of 1,137,405. Tenet Healthcare has a 1 year low of $87.06 and a 1 year high of $171.20. The firm has a market cap of $12.07 billion, a price-to-earnings ratio of 4.07, a P/E/G ratio of 0.63 and a beta of 2.05. The firm has a 50 day simple moving average of $133.55 and a 200 day simple moving average of $148.37. The company has a debt-to-equity ratio of 2.35, a quick ratio of 1.52 and a current ratio of 1.58.
Wall Street Analyst Weigh In
Several equities research analysts have weighed in on THC shares. Barclays reduced their price objective on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a research note on Thursday. The Goldman Sachs Group lowered Tenet Healthcare from a “buy” rating to a “neutral” rating and decreased their price target for the company from $196.00 to $140.00 in a report on Monday, December 16th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $175.00 price objective on shares of Tenet Healthcare in a research report on Tuesday, December 17th. Raymond James lowered shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 target price for the company. in a report on Friday, November 22nd. Finally, Truist Financial cut their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Three research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $163.19.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Further Reading
- Five stocks we like better than Tenet Healthcare
- Following Congress Stock Trades
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Breakout Stocks: What They Are and How to Identify Them
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- Top Stocks Investing in 5G Technology
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.